These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11282290)

  • 1. Androgen and estrogen stimulation of ornithine decarboxylase activity in mouse kidney.
    Svechnikov K; Ritzén EM; Holst M
    J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):329-33. PubMed ID: 11282290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen and progestin stimulation of ornithine decarboxylase activity in the mouse kidney.
    Bullock LP
    Endocrinology; 1983 Jun; 112(6):1903-9. PubMed ID: 6682754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
    Labrie C; Cusan L; Plante M; Lapointe S; Labrie F
    J Steroid Biochem; 1987 Oct; 28(4):379-84. PubMed ID: 2444770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.
    Kontula KK; Seppänen PJ; van Duyne P; Bardin CW; Jänne OA
    Endocrinology; 1985 Jan; 116(1):226-33. PubMed ID: 3964747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone suppression of ornithine decarboxylase activity in rat Sertoli cells.
    Swift TA; Dias JA
    Endocrinology; 1988 Aug; 123(2):687-93. PubMed ID: 2840265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal exposure to androgens alters renal ornithine decarboxylase ontogeny and abolishes renal sexual dimorphism in mice.
    Sánchez-Capelo A; Tejada F; Ruzafa C; Cremades A; Peñafiel R
    Biol Neonate; 1999 Aug; 76(2):72-83. PubMed ID: 10393991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiandrogenic effect of RU-486 in the mouse kidney.
    Tovar A; Sánchez-Capelo A; Galindo JD; Cremades A; Peñafiel R
    Int J Biochem Cell Biol; 1997 Feb; 29(2):361-6. PubMed ID: 9147138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a 15-day screening assay using intact male rats for identifying antiandrogens.
    O'Connor JC; Frame SR; Ladics GS
    Toxicol Sci; 2002 Sep; 69(1):92-108. PubMed ID: 12215663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ornithine decarboxylase activity as a marker of androgen and antiandrogen action in the rat epididymis.
    de las Heras MA; Suescun MO; Calandra RS
    J Reprod Fertil; 1988 May; 83(1):177-83. PubMed ID: 3397935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in androgen regulation of ornithine decarboxylase gene expression in inbred strains of mice.
    Melanitou E; Cohn DA; Bardin CW; Jänne OA
    Mol Endocrinol; 1987 Mar; 1(3):266-73. PubMed ID: 3453893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal development of ornithine decarboxylase and polyamines in the mouse kidney: influence of testosterone.
    Sánchez-Capelo A; Peñafiel R; Tovar A; Galindo JD; Cremades A
    Biol Neonate; 1994; 66(2-3):119-27. PubMed ID: 7993945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen-uterine interactions: an assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis.
    Schmidt WN; Katzenellenbogen BS
    Mol Cell Endocrinol; 1979 Aug; 15(2):91-108. PubMed ID: 499651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of renal N-nitrosodimethylamine demethylase activity by androgens, progestin, glucocorticoid, and estrogen in BALB/c mice.
    Ahir S; Mohla S
    Cancer Res; 1989 Jul; 49(14):3737-41. PubMed ID: 2786744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action and pure antiandrogenic properties of flutamide.
    Labrie F
    Cancer; 1993 Dec; 72(12 Suppl):3816-27. PubMed ID: 8252497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of the androgenic activity of anti-androgen].
    Imai K; Watanabe K; Takahashi O; Shimizu N; Nakata S; Kawashima K; Suzuki T; Yamanaka H
    Nihon Naibunpi Gakkai Zasshi; 1990 Jun; 66(6):597-606. PubMed ID: 1696915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle.
    Neubauer B; Blume C; Cricco R; Greiner J; Mawhinney M
    Invest Urol; 1981 Jan; 18(4):229-34. PubMed ID: 7451082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine and ornithine metabolizing enzymes in testosterone-induced hypertrophic mouse kidney.
    Manteuffel-Cymborowska M; Chmurzyńska W; Peska M; Grzelakowska-Sztabert B
    Int J Biochem Cell Biol; 1995 Mar; 27(3):287-95. PubMed ID: 7780833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ornithine decarboxylase mRNA in mouse kidney: a low abundancy gene product regulated by androgens with rapid kinetics.
    Jänne OA; Kontula KK; Isomaa VV; Bardin CW
    Ann N Y Acad Sci; 1984; 438():72-84. PubMed ID: 6598355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential androgen sensitivity is associated with clonal heterogeneity in steroid metabolism, ornithine decarboxylase regulation and IL-1alpha action in mouse mammary tumor cells.
    Hida N; Poulin R; Veilleux R; Labrie F
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):71-81. PubMed ID: 10619359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two forms of ornithine decarboxylase activity in mouse kidney.
    Loeb D; Houben PW; Bullock LP
    Mol Cell Endocrinol; 1984 Nov; 38(1):67-73. PubMed ID: 6519353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.